| scholarly article | Q13442814 |
| P50 | author | Susan L Stramer | Q66751416 |
| P2093 | author name string | Gregory A Foster | |
| Roger Y Dodd | |||
| David E Krysztof | |||
| Edward P Notari | |||
| Shimian Zou | |||
| Fatemeh Musavi | |||
| P2860 | cites work | Current incidence and residual risk of hepatitis B infection among blood donors in the United States. | Q50609667 |
| Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study. | Q50754171 | ||
| Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program | Q33288333 | ||
| Hepatitis B virus infection and transfusion medicine: science and the occult | Q37153782 | ||
| Changing age distribution of the blood donor population in the United States | Q40154046 | ||
| The consequences of temporary deferral on future whole blood donation | Q40190042 | ||
| Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen | Q41039958 | ||
| Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population | Q43040535 | ||
| Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen | Q43588340 | ||
| PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples | Q44012614 | ||
| Sensitivity comparison of two Food and Drug Administration-licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield | Q45363580 | ||
| Statements from the Taormina expert meeting on occult hepatitis B virus infection | Q45391959 | ||
| Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients | Q45781760 | ||
| Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study | Q45795744 | ||
| Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes. | Q45931918 | ||
| Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. | Q46004376 | ||
| Nucleic acid testing to detect HBV infection in blood donors. | Q50548264 | ||
| P433 | issue | 2 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| P304 | page(s) | 440-446 | |
| P577 | publication date | 2011-08-02 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? | |
| P478 | volume | 52 |
| Q35043752 | A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donors |
| Q45354619 | A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. |
| Q42257442 | A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening |
| Q92462643 | Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing |
| Q40962292 | Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA. |
| Q26752681 | Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India |
| Q42990781 | Comparative analysis of triplex nucleic acid test assays in United States blood donors |
| Q37376530 | Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants |
| Q54455524 | Epidemiology, performance characteristics, or both? |
| Q37135436 | Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico |
| Q35927983 | Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China |
| Q38223372 | Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? |
| Q36766479 | Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection |
| Q45351561 | Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? |
| Q35782725 | High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia. |
| Q44733718 | Infectivity of occult hepatitis B from two different points of view |
| Q38536404 | Molecular mechanisms underlying HBsAg negativity in occult HBV infection |
| Q42000342 | Nucleic acid testing-benefits and constraints |
| Q41111337 | Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing |
| Q35237335 | Occult hepatitis B virus infection and blood transfusion |
| Q30647985 | Predicting the presence of hepatitis B virus surface antigen in Chinese patients by pathology data mining |
| Q37232154 | Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA. |
| Q92821080 | Prevalence of antibodies against Hepatitis D virus (HDV) in blood donors in Northern Germany |
| Q36403550 | Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus |
| Q44583128 | Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan |
| Q27346471 | Risk factors for retrovirus and hepatitis virus infections in accepted blood donors |
| Q35623577 | T-Cell Response to Hepatitis B Core Antigen: Identification of Prior Exposure to and Confirmatory Testing for Screening for Anti-HBc. |
| Q98158909 | THE IMPACT OF POSITIVE ANTI-HBC MARKER ON PERMANENT DEFERRAL OF VOLUNTARY BLOOD DONORS IN EASTERN CROATIA AND ESTIMATION OF OCCULT HEPATITIS B VIRUS INFECTION RATE |
| Q41606333 | The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country |
| Q57176158 | Value of retaining HBsAg donor screening where HBV NAT and anti-HBc donor screening apply |
Search more.